Boundless Bio, Inc. Common Stock (BOLD) is a publicly traded Healthcare sector company. As of May 21, 2026, BOLD trades at $1.42 with a market cap of $31.90M and a P/E ratio of -0.55. BOLD moved +0.00% today. Year to date, BOLD is +20.34%; over the trailing twelve months it is -14.46%. Its 52-week range spans $0.96 to $3.75. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BOLD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Boundless Bio, Inc. Common Stock (BOLD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BOLD moved +0.00% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $1.42 |
| Market Cap | $31.90M |
| P/E Ratio | -0.55 |
| EPS | $-2.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.75 |
| 52-Week Low | $0.96 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-58.20M |
| Gross Margin | 0.00% |
1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.